European Journal of Cancer
Volume 42, Issue 15 , Pages 2425-2432, October 2006

A genomic explanation connecting “Mediterranean diet”, olive oil and cancer: Oleic acid, the main monounsaturated Fatty acid of olive oil, induces formation of inhibitory “PEA3 transcription factor-PEA3 DNA binding site” complexes at the Her-2/neu (erbB-2) oncogene promoter in breast, ovarian and stomach cancer cells

  • Javier A. Menendez

      Affiliations

    • Department of Medicine, Evanston Northwestern Healthcare Research Institute, 1001 University Place, Evanston, IL 60201, USA
    • Department of Medicine, Northwestern University Feinberg, School of Medicine, Chicago, IL, USA
    • Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL, USA
  • ,
  • Adriana Papadimitropoulou

      Affiliations

    • Department of Medicine, Evanston Northwestern Healthcare Research Institute, 1001 University Place, Evanston, IL 60201, USA
    • Department of Medicine, Northwestern University Feinberg, School of Medicine, Chicago, IL, USA
  • ,
  • Luciano Vellon

      Affiliations

    • Department of Medicine, Evanston Northwestern Healthcare Research Institute, 1001 University Place, Evanston, IL 60201, USA
    • Department of Medicine, Northwestern University Feinberg, School of Medicine, Chicago, IL, USA
  • ,
  • Ruth Lupu

      Affiliations

    • Department of Medicine, Evanston Northwestern Healthcare Research Institute, 1001 University Place, Evanston, IL 60201, USA
    • Department of Medicine, Northwestern University Feinberg, School of Medicine, Chicago, IL, USA
    • Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL, USA
    • Corresponding Author InformationCorresponding author: Tel.: +1 224 364 7671/7672; fax: +1 847 570 8022.

Received 16 August 2005; accepted 3 October 2005.

Abstract 

Olive oil is an integral ingredient of the “Mediterranean diet” and accumulating evidence suggests that it may have a potential role in lowering risk of several cancers. We recently hypothesized that the anti-cancer actions of olive oil may relate to its monounsaturated fatty acid (MUFA) oleic acid (OA; 18:1n9) content to specifically regulate oncogenes. In this study, transient transfection experiments with human Her-2/neu promoter-driven luciferase gene established the ability of OA to specifically repress the transcriptional activity of Her-2/neu gene. Gene repression was seen in tumour-derived cell lines with Her-2/neu gene amplification and overexpression, including SK-Br3 (⩽56% reduction), SK-OV3 (⩽75% reduction) and NCI-N87 (55% reduction) breast, ovarian and stomach cancer cell lines, respectively. Also marginal decreases in promoter activity were observed in cancer cells expressing physiological levels of Her-2/neu (⩽20% reduction in MCF-7 breast cancer cells). Remarkably, OA treatment in Her-2/neu-overexpressing cancer cells was found to induce up-regulation of the Ets protein polyomavirus enhancer activator 3 (PEA3), a transcriptional repressor of Her-2/neu promoter. Also, an intact PEA3 DNA-binding-site at endogenous Her-2/neu gene promoter was essential for OA-induced repression of this gene. Moreover, OA treatment failed to decrease Her-2/neu protein levels in MCF-7/Her2-18 transfectants, which stably express full-length human Her-2/neu cDNA controlled by a SV40 viral promoter. OA-induced transcriptional repression of Her-2/neu through the action of PEA3 protein at the promoter level may represent a novel mechanism linking “Mediterranean diet” and cancer.

Keywords: Her-2/neu, erbB-2, PEA3, Oleic acid, Olive oil, Mediterranean diet, Cancer

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0959-8049(05)00935-4

doi:10.1016/j.ejca.2005.10.016

European Journal of Cancer
Volume 42, Issue 15 , Pages 2425-2432, October 2006